The solution structure and oligomerization behavior of two bacterial toxins: pneumolysin and perfringolysin O

Biophysical Journal
Alexandra S SolovyovaO Byron

Abstract

Pneumolysin (PLY), an important protein virulence factor of the human bacterial pathogen Streptococcus pneumoniae, could be a candidate for inclusion in a new anti-streptococcal vaccine. PLY solution species from monomer via multimeric intermediates to ring-shaped oligomers were studied with time-dependent sedimentation velocity in the analytical ultracentrifuge (AUC). Hydrodynamic bead modeling was used to interpret the data obtained. PLY remained mostly monomeric in solution; intermediate PLY multimers were detected in small quantities. Current understanding of PLY molecular mechanism is guided by a model built on the basis of its homology with perfringolysin O (PFO) for which there is an atomic structure. PFO, a virulence factor of the organism Clostridium perfringens, has almost the same molecular mass as PLY and shares 48% sequence identity and 60% sequence similarity with PLY. We report a comparative low-resolution structural study of PLY and PFO using AUC and small-angle x-ray scattering (SAXS). AUC data demonstrate that both proteins in solution are mostly monodisperse but PLY is a monomer whereas PFO is mostly dimeric. Ab initio dummy atom and dummy residue models for PFO and PLY were restored from the distance distrib...Continue Reading

References

Jan 23, 1989·Biochimica Et Biophysica Acta·T J MitchellG J Boulnois
Aug 1, 1994·Biophysical Journal·J Garcia de la TorreJ J Lopez Cascales
Feb 1, 1993·Biopolymers·B S Duncan, A J Olson
Dec 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D CundellE I Tuomanen
Nov 14, 1998·Journal of Molecular Biology·J RossjohnM W Parker
Dec 5, 1998·Journal of Molecular Biology·R J GilbertO Byron
Mar 20, 1995·Physical Review Letters·B Hesselbo, R B Stinchcombe
Feb 2, 2000·Biophysical Journal·J García De La TorreB Carrasco
Jul 15, 2000·The Journal of Biological Chemistry·S S FunariD I Svergun
Jul 26, 2000·Methods in Enzymology·O Byron
Sep 6, 2000·The Journal of Biological Chemistry·M A PeruginiG J Howlett
Oct 29, 2000·Acta Crystallographica. Section D, Biological Crystallography·S J Kelly, M J Jedrzejas
May 24, 2001·Biophysical Journal·D I SvergunM H Koch
Aug 2, 2001·Biochemistry·A P HeuckA E Johnson
Sep 29, 2001·The Journal of Biological Chemistry·A SokolovaR Tuma
Oct 12, 2001·Toxicon : Official Journal of the International Society on Toxinology·M Palmer
Feb 6, 2002·Journal of Molecular Biology·David J ScottBen R Otto
Jun 29, 2002·Cellular and Molecular Life Sciences : CMLS·R J C Gilbert
Aug 15, 2002·The Journal of Biological Chemistry·Patrice VachetteBenedetto Salvato
Oct 9, 2002·Nature Structural Biology·Rajesh RamachandranArthur E Johnson
Nov 26, 2002·The Journal of Biological Chemistry·Peijian ZouDmitri I Svergun
Dec 5, 2002·Current Opinion in Structural Biology·Dmitri I Svergun, Michel H J Koch
Dec 18, 2002·The Journal of Biological Chemistry·Simonetta BernoccoDavid J S Hulmes
Dec 24, 2002·Biophysical Journal·Maxim V PetoukhovDmitri I Svergun
Jan 14, 2003·Biophysical Journal·Claire J AckermanOlwyn Byron
Mar 1, 1964·Biochemistry·D A YPHANTIS
Apr 28, 2004·Biophysical Journal·Marcelo NöllmannOlwyn Byron

❮ Previous
Next ❯

Citations

May 9, 2006·Journal of Burn Care & Research : Official Publication of the American Burn Association·Kurt A MelstromRavi Shankar
Aug 7, 2009·Journal of the Royal Society, Interface·Jeremy H Lakey
May 27, 2015·Toxins·Stefanie VerherstraetenFilip Van Immerseel
May 12, 2012·FEBS Letters·Mads GabrielsenAndrew J Roe
Feb 26, 2016·European Biophysics Journal : EBJ·Robert J C Gilbert, Andreas F-P Sonnen
Mar 3, 2007·Journal of Molecular Biology·Jamie RossjohnMichael W Parker
Oct 26, 2011·The FEBS Journal·Andrej BavdekGregor Anderluh
Mar 28, 2006·Current Opinion in Structural Biology·Sarah J Tilley, Helen R Saibil
Jan 9, 2014·The Journal of Biological Chemistry·Qingqing Lin, Erwin London
Mar 18, 2016·The Journal of Biological Chemistry·Monika Bokori-BrownC Peter Winlove
May 21, 2008·Current Protocols in Immunology·Patrick H BrownPeter Schuck
Aug 10, 2019·Biochemical and Biophysical Research Communications·Fang-Feng ChiuShih-Jen Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.